MelliCell Inc. Awarded Competitive Grant from the U.S. National Science Foundation
NEWTON, Mass., March 28, 2024 /PRNewswire/ -- MelliCell Inc. has been awarded a U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $275,000 to conduct research and development (R&D) work on "Industrial Scale Technology for Drug Development in Mature Human Fat Cells." This project underscores MelliCell's commitment to revolutionizing obesity treatment by leveraging cellular-level insights to address the root causes of this global health challenge. The company's innovative approach promises to improve patient outcomes by tapping into the therapeutic potential of mature human fat cells.
- NEWTON, Mass., March 28, 2024 /PRNewswire/ -- MelliCell Inc. has been awarded a U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $275,000 to conduct research and development (R&D) work on "Industrial Scale Technology for Drug Development in Mature Human Fat Cells."
- The company's innovative approach promises to improve patient outcomes by tapping into the therapeutic potential of mature human fat cells.
- Once a small business is awarded a Phase I grant, it becomes eligible to apply for Phase II funding and additional supplements totaling up to $2 million.
- To learn more about how NSF helps unlock future technologies for national and societal impact, visit: https://beta.nsf.gov/tip/latest .